Michael Mano's most recent trade in Karyopharm Therapeutics Inc was a trade of 612 Common Stock done . Disclosure was reported to the exchange on Sept. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2025 | 612 | 21,659 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 6.43 per share. | 12 Sep 2025 | 234 | 21,425 (0%) | 0% | 6.4 | 1,505 | Common Stock |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 04 Mar 2025 | 2,793 | 21,047 (0%) | 0% | 6.3 | 17,568 | Common Stock |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 6,666 | 6,666 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 3,333 | 21,590 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 2,250 | 23,840 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 04 Sep 2024 | 3,971 | 273,881 (0%) | 0% | 0.7 | 2,866 | Common Stock |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 29 Feb 2024 | 16,973 | 281,428 (0%) | 0% | 1.2 | 19,858 | Common |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 29 Feb 2024 | 3,576 | 277,852 (0%) | 0% | 1.2 | 4,291 | Common |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 147,000 | 298,401 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Mano Michael | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 9,167 | 151,401 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 70,000 | 153,000 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 28 Feb 2023 | 6,878 | 146,122 (0%) | 0% | 3.0 | 20,835 | Common Stock |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 20,000 | 83,000 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 81,000 | 81,000 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 63,000 | 63,000 (0%) | 0% | 0 | Common Stock |